IP Library Granted Patent US 10,201,621
Granted Patent B2
US 10,201,621 · App. 15/633,233 · Granted Feb 12, 2019

Charge-balanced imaging agents

Inventors: John V. Frangioni (Wayland, MA); Maged M. Henary (Lawrenceville, GA)
Assignees: Beth Israel Deaconess Medical Center, Inc.; Georgia State University Research Foundation Inc.
A61K49/0032A61B6/00C07D209/02C07D209/42C07D255/02C09B23/0066C09B23/086C12Q1/02G01N33/582
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,201,621
App. No.
15/633,233
Granted
Feb 12, 2019
Kind
B2
Abstract

The present invention relates to compositions for and methods of optically imaging tissues or cells using imaging agents having desirable in vivo properties that result in improved signal-to-background ratio.

Claims (34)

1. A method of imaging tissue or cells, the method comprising:

(a) contacting the tissue or cells with an imaging agent comprising a dye;

(b) irradiating the tissue or cells at a wavelength absorbed by the dye;

(c) detecting an optical signal from the irradiated tissue or cells, wherein the signal-to-background ratio of the detected optical signal is at least about 1.1, thereby imaging the tissue or cells;

wherein the dye has the formula:

or an ester thereof , which permits covalent conjugation of the fluorophore to targeting ligands,

wherein:

E is absent, O or S;

Q is (CH 2 ) q or a non-ionic oligomeric or polymeric solubilizing moiety;

J is C(O), C(O)O, or C(O)NH;

R 17 , R 18 , R 19 , and R 20 are independently selected from H, an ionic group, a non-ionic oligomeric or polymeric solubilizing moiety, halo, cyano, nitro, C 1-4 alkyl, C 1-4 alkoxy, and C 1-4 haloalkyl; and

q is 0, 1, 2, 3, 4, 5, 6, 7, or 8.

2. A dye, having the formula:

or an ester thereof , which permits covalent conjugation of the fluorophore to targeting ligands,

wherein:

E is absent, O or S;

Q is (CH 2 ) q or a non-ionic oligomeric or polymeric solubilizing moiety;

J is C(O), C(O)O, or C(O)NH;

R 17 , R 18 , R 19 , and R 20 are independently selected from H, an ionic group, a non-ionic oligomeric or polymeric solubilizing moiety, halo, cyano, nitro, C 1-4 alkyl, C 1-4 alkoxy, and C 1-4 haloalkyl; and

q is 0, 1, 2, 3, 4, 5, 6, 7, or 8.

3. The dye of claim 2 , wherein the ester is a N-hydroxysuccinimide ester.

4. The dye of claim 2 , isolated as a salt, acid, or combination thereof.

5. An imaging agent comprising the dye of claim 2 which is characterized as having detectable fluorescence with a signal-to-background ratio of at least about 1.1.

6. A method of imaging tissue or cells, the method comprising:

(a) contacting the tissue or cells with an imaging agent comprising a dye;

(b) irradiating the tissue or cells at a wavelength absorbed by the dye;

(c) detecting an optical signal from the irradiated tissue or cells, wherein the signal-to-background ratio of the detected optical signal is at least about 1.1, thereby imaging the tissue or cells;

wherein the dye has the formula:

or an ester thereof , which permits covalent conjugation of the fluorophore to targeting ligands.

7. A dye, having the formula:

or an ester thereof, which permits covalent conjugation of the fluorophore to targeting ligands.

8. The dye of claim 7 , wherein the ester is a N-hydroxysuccinimide ester.

9. The dye of claim 7 , isolated as a salt, acid, or combination thereof.

10. An imaging agent comprising the dye of claim 7 which is characterized as having detectable fluorescence with a signal-to-background ratio of at least about 1.1.

Continuity (4)
Continuation 14681068 · Apr 7, 2015
Continuation 13148137
Provisional Application 61150522 · Feb 6, 2009
Related Publication 20170290927A1 · Oct 12, 2017
Cited By (4)
US 12,440,585 US 12,545,641 US 12,559,476 US 12,661,416